Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and betadex

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with betadex in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(betadex)		Trials
(betadex)		Recent Studies (post-2010) (betadex)
9,1561875528,785974,452

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barabé, F; Bourgoin, SG; Fernandes, MJ; Naccache, PH; Paré, G1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and betadex

ArticleYear
Cholesterol-modulating agents selectively inhibit calcium influx induced by chemoattractants in human neutrophils.
    The Journal of biological chemistry, 2002, Apr-19, Volume: 277, Issue:16

    Topics: beta-Cyclodextrins; Calcium; Cell Membrane; Cholesterol; Cyclodextrins; Cytoplasm; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipase D; Phosphorylation; Platelet Activating Factor; Protein Structure, Tertiary; Superoxides; Time Factors; Tyrosine

2002